David A. Siegel Procept Bio Robotics Corp Transaction History
Two Sigma Advisers, LP
- $42.5 Billion
- Q1 2024
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Two Sigma Advisers, LP holds 93,400 shares of PRCT stock, worth $5.9 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
93,400Holding current value
$5.9 Million% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding PRCT
# of Institutions
173Shares Held
38.1MCall Options Held
386KPut Options Held
259K-
Cpmg Inc Dallas, TX5.33MShares$337 Million100.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.25MShares$268 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.29MShares$208 Million0.0% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD2.94MShares$186 Million0.09% of portfolio
-
Alliancebernstein L.P. New York, NY1.99MShares$125 Million0.04% of portfolio
About PROCEPT BioRobotics Corp
- Ticker PRCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 44,592,300
- Market Cap $2.82B
- Description
- PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...